# Albany International Corp: financial statements, quarterly

AIN · NYSE · CIK 819793 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ain.md) · [Financials](/companies/ain/financials.md) · [Filings](/companies/ain/filings.md) · [Insiders](/companies/ain/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ain/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [281](/filings/0000819793-24-000071.md) | [324 d](/filings/0001628280-26-012906.md) | [313](/filings/0001628280-25-021110.md) | [332](/filings/0000819793-25-000032.md) | [298](/filings/0001628280-25-050028.md) | [287 d](/filings/0001628280-26-012906.md) | [289](/filings/0001628280-26-028744.md) | [311](/filings/0001628280-26-052329.md) | [261](/filings/0001628280-25-050028.md) | [321 d](/filings/0001628280-26-012906.md) | [311](/filings/0001628280-26-028744.md) | [329](/filings/0001628280-26-052329.md) |
| Cost of revenue | $m | [179](/filings/0000819793-24-000071.md) | [204 d](/filings/0001628280-26-012906.md) | [205](/filings/0001628280-25-021110.md) | [220](/filings/0000819793-25-000032.md) | [208](/filings/0001628280-25-050028.md) | [197 d](/filings/0001628280-26-012906.md) | [192](/filings/0001628280-26-028744.md) | [214](/filings/0001628280-26-052329.md) | [311](/filings/0001628280-25-050028.md) | [221 d](/filings/0001628280-26-012906.md) | [212](/filings/0001628280-26-028744.md) | [222](/filings/0001628280-26-052329.md) |
| Gross profit | $m | [102](/filings/0000819793-24-000071.md) | [120 d](/filings/0001628280-26-012906.md) | [109](/filings/0001628280-25-021110.md) | [112](/filings/0000819793-25-000032.md) | [90.4](/filings/0001628280-25-050028.md) | [90.3 d](/filings/0001628280-26-012906.md) | [96.5](/filings/0001628280-26-028744.md) | [97.5](/filings/0001628280-26-052329.md) | [(49.9)](/filings/0001628280-25-050028.md) | [99.9 d](/filings/0001628280-26-012906.md) | [99.8](/filings/0001628280-26-028744.md) | [108](/filings/0001628280-26-052329.md) |
| Selling, general and administrative | $m | [52.0](/filings/0000819793-24-000071.md) | [67.7 d](/filings/0001628280-26-012906.md) | [54.8](/filings/0001628280-25-021110.md) | [55.5](/filings/0000819793-25-000032.md) | [52.1](/filings/0001628280-25-050028.md) | [48.4 d](/filings/0001628280-26-012906.md) | [53.8](/filings/0001628280-26-028744.md) | [58.5](/filings/0001628280-26-052329.md) | [51.9](/filings/0001628280-25-050028.md) | [54.1 d](/filings/0001628280-26-012906.md) | [58.3](/filings/0001628280-26-028744.md) | [56.1](/filings/0001628280-26-052329.md) |
| Operating income | $m | [40.1](/filings/0000819793-24-000071.md) | [41.8 d](/filings/0001628280-26-012906.md) | [39.0](/filings/0001628280-25-021110.md) | [42.9](/filings/0000819793-25-000032.md) | [25.2](/filings/0001628280-25-050028.md) | [24.3 d](/filings/0001628280-26-012906.md) | [28.3](/filings/0001628280-26-028744.md) | [22.3](/filings/0001628280-26-052329.md) | [(117)](/filings/0001628280-25-050028.md) | [29.9 d](/filings/0001628280-26-012906.md) | [25.4](/filings/0001628280-26-028744.md) | [32.1](/filings/0001628280-26-052329.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.2](/filings/0000819793-24-000071.md) | [8.9 d](/filings/0001628280-26-012906.md) | [11.3](/filings/0001628280-25-021110.md) | [9.6](/filings/0000819793-25-000032.md) | [1.3](/filings/0001628280-25-050028.md) | [6.9 d](/filings/0001628280-26-012906.md) | [6.3](/filings/0001628280-26-028744.md) | [4.3](/filings/0001628280-26-052329.md) | [(24.4)](/filings/0001628280-25-050028.md) | [9.1 d](/filings/0001628280-26-012906.md) | [7.7](/filings/0001628280-26-028744.md) | [8.3](/filings/0001628280-26-052329.md) |
| Net income | $m | [27.1](/filings/0000819793-24-000071.md) | [30.5 d](/filings/0001628280-26-012906.md) | [27.3](/filings/0001628280-25-021110.md) | [24.6](/filings/0000819793-25-000032.md) | [18.0](/filings/0001628280-25-050028.md) | [17.7 d](/filings/0001628280-26-012906.md) | [17.4](/filings/0001628280-26-028744.md) | [9.2](/filings/0001628280-26-052329.md) | [(97.8)](/filings/0001628280-25-050028.md) | [13.9 d](/filings/0001628280-26-012906.md) | [15.3](/filings/0001628280-26-028744.md) | [17.4](/filings/0001628280-26-052329.md) |
| Diluted EPS | $ per share | [0.87](/filings/0000819793-24-000071.md) | not reported | [0.87](/filings/0001628280-25-021110.md) | [0.79](/filings/0000819793-25-000032.md) | [0.57](/filings/0001628280-25-050028.md) | not reported | [0.56](/filings/0001628280-26-028744.md) | [0.31](/filings/0001628280-26-052329.md) | [(3.37)](/filings/0001628280-25-050028.md) | not reported | [0.54](/filings/0001628280-26-028744.md) | [0.61](/filings/0001628280-26-052329.md) |
| Basic EPS | $ per share | [0.87](/filings/0000819793-24-000071.md) | not reported | [0.87](/filings/0001628280-25-021110.md) | [0.79](/filings/0000819793-25-000032.md) | [0.58](/filings/0001628280-25-050028.md) | not reported | [0.56](/filings/0001628280-26-028744.md) | [0.31](/filings/0001628280-26-052329.md) | [(3.37)](/filings/0001628280-25-050028.md) | not reported | [0.54](/filings/0001628280-26-028744.md) | [0.61](/filings/0001628280-26-052329.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [172](/filings/0000819793-23-000090.md) | [173](/filings/0000819793-25-000007.md) | [125](/filings/0000819793-24-000033.md) | [116](/filings/0000819793-24-000051.md) | [127](/filings/0000819793-24-000071.md) | [115](/filings/0001628280-26-012906.md) | [119](/filings/0001628280-25-021110.md) | [107](/filings/0000819793-25-000032.md) | [108](/filings/0001628280-25-050028.md) | [112](/filings/0001628280-26-052329.md) | [123](/filings/0001628280-26-028744.md) | [77.3](/filings/0001628280-26-052329.md) |
| Current assets | $m | [856](/filings/0000819793-23-000090.md) | [878](/filings/0000819793-25-000007.md) | [845](/filings/0000819793-24-000033.md) | [806](/filings/0000819793-24-000051.md) | [804](/filings/0000819793-24-000071.md) | [731](/filings/0001628280-26-012906.md) | [768](/filings/0001628280-25-021110.md) | [775](/filings/0000819793-25-000032.md) | [741](/filings/0001628280-25-050028.md) | [929](/filings/0001628280-26-052329.md) | [963](/filings/0001628280-26-028744.md) | [941](/filings/0001628280-26-052329.md) |
| Total assets | $m | [1,790](/filings/0000819793-23-000090.md) | [1,835](/filings/0001628280-26-012906.md) | [1,798](/filings/0000819793-24-000033.md) | [1,752](/filings/0000819793-24-000051.md) | [1,753](/filings/0000819793-24-000071.md) | [1,649](/filings/0001628280-26-012906.md) | [1,688](/filings/0001628280-25-021110.md) | [1,723](/filings/0000819793-25-000032.md) | [1,702](/filings/0001628280-25-050028.md) | [1,719](/filings/0001628280-26-052329.md) | [1,737](/filings/0001628280-26-028744.md) | [1,711](/filings/0001628280-26-052329.md) |
| Current liabilities | $m | [243](/filings/0000819793-23-000090.md) | [249](/filings/0000819793-25-000007.md) | [212](/filings/0000819793-24-000033.md) | [225](/filings/0000819793-24-000051.md) | [219](/filings/0000819793-24-000071.md) | [226](/filings/0001628280-26-012906.md) | [208](/filings/0001628280-25-021110.md) | [221](/filings/0000819793-25-000032.md) | [316](/filings/0001628280-25-050028.md) | [442](/filings/0001628280-26-052329.md) | [439](/filings/0001628280-26-028744.md) | [421](/filings/0001628280-26-052329.md) |
| Total liabilities | $m | [869](/filings/0000819793-23-000090.md) | [868](/filings/0000819793-25-000007.md) | [825](/filings/0000819793-24-000033.md) | [778](/filings/0000819793-24-000051.md) | [757](/filings/0000819793-24-000071.md) | [700](/filings/0001628280-26-012906.md) | [783](/filings/0001628280-25-021110.md) | [829](/filings/0000819793-25-000032.md) | [957](/filings/0001628280-25-050028.md) | [987](/filings/0001628280-26-052329.md) | [1,001](/filings/0001628280-26-028744.md) | [959](/filings/0001628280-26-052329.md) |
| Long-term debt | $m | [463](/filings/0000819793-23-000090.md) | [453](/filings/0000819793-25-000007.md) | [435](/filings/0000819793-24-000033.md) | [374](/filings/0000819793-24-000051.md) | [362](/filings/0000819793-24-000071.md) | [319](/filings/0001628280-26-012906.md) | [416](/filings/0001628280-25-021110.md) | [445](/filings/0000819793-25-000032.md) | [481](/filings/0001628280-25-050028.md) | [456](/filings/0001628280-26-052329.md) | [477](/filings/0001628280-26-028744.md) | [451](/filings/0001628280-26-052329.md) |
| Current portion of debt | $m | [27.2](/filings/0000819793-23-000090.md) | [4.2](/filings/0000819793-25-000007.md) | [4.4](/filings/0000819793-24-000033.md) | [2.7](/filings/0000819793-24-000051.md) | [0.6](/filings/0000819793-24-000071.md) | [0.0](/filings/0001628280-26-012906.md) | [0.0](/filings/0001628280-25-021110.md) | [0.0](/filings/0000819793-25-000032.md) | [0.0](/filings/0001628280-25-050028.md) | [0.0](/filings/0001628280-26-052329.md) | [0.0](/filings/0001628280-26-028744.md) | [0.0](/filings/0001628280-26-052329.md) |
| Shareholders' equity | $m | [915](/filings/0000819793-23-000090.md) | [961](/filings/0000819793-25-000007.md) | [967](/filings/0000819793-24-000033.md) | [968](/filings/0000819793-24-000051.md) | [991](/filings/0000819793-24-000071.md) | [944](/filings/0001628280-26-012906.md) | [900](/filings/0001628280-25-021110.md) | [889](/filings/0000819793-25-000032.md) | [739](/filings/0001628280-25-050028.md) | [726](/filings/0001628280-26-052329.md) | [729](/filings/0001628280-26-028744.md) | [746](/filings/0001628280-26-052329.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [59.1 d](/filings/0000819793-24-000071.md) | [74.2 d](/filings/0001628280-26-012906.md) | [9.6](/filings/0001628280-25-021110.md) | [83.4 d](/filings/0000819793-25-000032.md) | [47.0 d](/filings/0001628280-25-050028.md) | [78.5 d](/filings/0001628280-26-012906.md) | [2.1](/filings/0001628280-26-028744.md) | [32.7 d](/filings/0001628280-26-052329.md) | [43.9 d](/filings/0001628280-25-050028.md) | [73.7 d](/filings/0001628280-26-012906.md) | [5.6](/filings/0001628280-26-028744.md) | [(2.7) d](/filings/0001628280-26-052329.md) |
| Capital expenditure | $m | [14.0 d](/filings/0000819793-24-000071.md) | [34.7 d](/filings/0001628280-26-012906.md) | [26.9](/filings/0001628280-25-021110.md) | [19.8 d](/filings/0000819793-25-000032.md) | [15.4 d](/filings/0001628280-25-050028.md) | [18.3 d](/filings/0001628280-26-012906.md) | [15.6](/filings/0001628280-26-028744.md) | [13.9 d](/filings/0001628280-26-052329.md) | [18.0 d](/filings/0001628280-25-050028.md) | [22.3 d](/filings/0001628280-26-012906.md) | [9.3](/filings/0001628280-26-028744.md) | [11.9 d](/filings/0001628280-26-052329.md) |
| Dividends paid | $m | [7.8 d](/filings/0000819793-24-000071.md) | [7.8 d](/filings/0001628280-26-012906.md) | [8.1](/filings/0001628280-25-021110.md) | [8.1 d](/filings/0000819793-25-000032.md) | [8.1 d](/filings/0001628280-25-050028.md) | [8.1 d](/filings/0001628280-26-012906.md) | [8.4](/filings/0001628280-26-028744.md) | [8.3 d](/filings/0001628280-26-052329.md) | [8.0 d](/filings/0001628280-25-050028.md) | [7.7 d](/filings/0001628280-26-012906.md) | [7.9](/filings/0001628280-26-028744.md) | [7.9 d](/filings/0001628280-26-052329.md) |
| Share repurchases | $m | [0.0 d](/filings/0000819793-23-000090.md) | [0.0 d](/filings/0001628280-26-012906.md) | [0.0](/filings/0001628280-25-021110.md) | [0.0 d](/filings/0000819793-25-000032.md) | [0.0 d](/filings/0001628280-25-050028.md) | [14.2 d](/filings/0001628280-26-012906.md) | [69.2](/filings/0001628280-26-028744.md) | [51.3 d](/filings/0001628280-26-052329.md) | [50.5 d](/filings/0001628280-25-050028.md) | [15.0 d](/filings/0001628280-26-012906.md) | [0.0](/filings/0001628280-26-028744.md) | [0.0 d](/filings/0001628280-26-052329.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.2](/filings/0000819793-23-000090.md) | [31.2](/filings/0000819793-24-000033.md) | [31.3](/filings/0000819793-24-000051.md) | [31.3](/filings/0000819793-24-000071.md) | [31.3](/filings/0001628280-25-021110.md) | [31.3](/filings/0000819793-25-000032.md) | [31.4](/filings/0001628280-25-050028.md) | [31.0](/filings/0001628280-26-028744.md) | [30.1](/filings/0001628280-26-052329.md) | [29.0](/filings/0001628280-25-050028.md) | [28.6](/filings/0001628280-26-028744.md) | [28.6](/filings/0001628280-26-052329.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,400,000 at 2026-07-15, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052329.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.